Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of Clobazam in Treating Anxiety Comorbid With Pediatric Epilepsy

NCT03371836 is registered in ClinicalTrials.gov with Hugo W. Moser Research Institute at Kennedy Krieger, Inc. as lead sponsor.

NCT NCT03371836
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03371836 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of Clobazam in Treating Anxiety Comorbid With Pediatric Epilepsy
Lead sponsor
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
Phase
Phase 4
Overall status
Completed
Start date
October 1, 2017
Completion date
December 31, 2019
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anxiety, epilepsy